REPORT ID 5118

United States Vaccine Adjuvants Market Report 2017

Publish Date
20-Dec-17
Pages
98
Format
Electronic (PDF)

In this report, the United States Vaccine Adjuvants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Vaccine Adjuvants in these regions, from 2012 to 2022 (forecast).

United States Vaccine Adjuvants market competition by top manufacturers/players, with Vaccine Adjuvants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    SEPPIC
    SDA BIO
    Brenntag Biosector
    SPI Pharma
    MVP Laboratories
    Tj Kaiwei
    Novavax
    Zhuoyue
    Aphios

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Oral
    Subcutaneous
    Intramuscular
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Human Vaccine Adjuvants
    Veterinary Vaccine Adjuvants

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Vaccine Adjuvants Market Report 2017
1 Vaccine Adjuvants Overview
    1.1 Product Overview and Scope of Vaccine Adjuvants
    1.2 Classification of Vaccine Adjuvants by Product Category
        1.2.1 United States Vaccine Adjuvants Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Vaccine Adjuvants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Oral
        1.2.4 Subcutaneous
        1.2.5 Intramuscular
        1.2.6 Others
    1.3 United States Vaccine Adjuvants Market by Application/End Users
        1.3.1 United States Vaccine Adjuvants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Human Vaccine Adjuvants
        1.3.3 Veterinary Vaccine Adjuvants
    1.4 United States Vaccine Adjuvants Market by Region
        1.4.1 United States Vaccine Adjuvants Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Vaccine Adjuvants Status and Prospect (2012-2022)
        1.4.3 Southwest Vaccine Adjuvants Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Vaccine Adjuvants Status and Prospect (2012-2022)
        1.4.5 New England Vaccine Adjuvants Status and Prospect (2012-2022)
        1.4.6 The South Vaccine Adjuvants Status and Prospect (2012-2022)
        1.4.7 The Midwest Vaccine Adjuvants Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Vaccine Adjuvants (2012-2022)
        1.5.1 United States Vaccine Adjuvants Sales and Growth Rate (2012-2022)
        1.5.2 United States Vaccine Adjuvants Revenue and Growth Rate (2012-2022)

2 United States Vaccine Adjuvants Market Competition by Players/Suppliers
    2.1 United States Vaccine Adjuvants Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Vaccine Adjuvants Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Vaccine Adjuvants Average Price by Players/Suppliers (2012-2017)
    2.4 United States Vaccine Adjuvants Market Competitive Situation and Trends
        2.4.1 United States Vaccine Adjuvants Market Concentration Rate
        2.4.2 United States Vaccine Adjuvants Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Type

3 United States Vaccine Adjuvants Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Vaccine Adjuvants Sales and Market Share by Region (2012-2017)
    3.2 United States Vaccine Adjuvants Revenue and Market Share by Region (2012-2017)
    3.3 United States Vaccine Adjuvants Price by Region (2012-2017)

4 United States Vaccine Adjuvants Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Vaccine Adjuvants Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Vaccine Adjuvants Revenue and Market Share by Type (2012-2017)
    4.3 United States Vaccine Adjuvants Price by Type (2012-2017)
    4.4 United States Vaccine Adjuvants Sales Growth Rate by Type (2012-2017)

5 United States Vaccine Adjuvants Sales (Volume) by Application (2012-2017)
    5.1 United States Vaccine Adjuvants Sales and Market Share by Application (2012-2017)
    5.2 United States Vaccine Adjuvants Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Vaccine Adjuvants Players/Suppliers Profiles and Sales Data
    6.1 SEPPIC
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Vaccine Adjuvants Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 SDA BIO
        6.2.2 Vaccine Adjuvants Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Brenntag Biosector
        6.3.2 Vaccine Adjuvants Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 SPI Pharma
        6.4.2 Vaccine Adjuvants Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 MVP Laboratories
        6.5.2 Vaccine Adjuvants Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Tj Kaiwei
        6.6.2 Vaccine Adjuvants Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Novavax
        6.7.2 Vaccine Adjuvants Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Zhuoyue
        6.8.2 Vaccine Adjuvants Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Aphios
        6.9.2 Vaccine Adjuvants Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Vaccine Adjuvants Manufacturing Cost Analysis
    7.1 Vaccine Adjuvants Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Vaccine Adjuvants

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Vaccine Adjuvants Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Vaccine Adjuvants Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Vaccine Adjuvants Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Vaccine Adjuvants Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Vaccine Adjuvants Sales Volume Forecast by Type (2017-2022)
    11.3 United States Vaccine Adjuvants Sales Volume Forecast by Application (2017-2022)
    11.4 United States Vaccine Adjuvants Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer